RecruitingPhase 2NCT07186101
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
Sponsor: Eli Lilly and Company
Hialeah, FL · Jacksonville, FL · Kissimmee, FL · +37 more sites
1 recruiting ulcerative colitis studies with a site in Lighthouse PT, FL.
All trials in Lighthouse PT, FL · All Ulcerative Colitis trials
Sponsor: Eli Lilly and Company
Hialeah, FL · Jacksonville, FL · Kissimmee, FL · +37 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.